The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.
Mol Cell Proteomics. 2012 Dec;11(12):1870-84
Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Mol Cell Proteomics. 2012 Nov;11(11):1404-15
FEBS J. 2012 Oct;279(20):3952-64
Circ Cardiovasc Genet. 2012 Jun;5(3):377
Proteomic profiling of the planarian Schmidtea mediterranea and its mucous reveals similarities with human secretions and those predicted for parasitic flatworms.
Mol Cell Proteomics. 2012 Sep;11(9):681-91
Dev Cell. 2012 Apr 17;22(4):887-901
Genome Biol. 2012;13(2):R11
Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.
J Proteome Res. 2012 Apr 6;11(4):2386-96
J Interferon Cytokine Res. 2012 Mar;32(3):127-37
The replication-independent histone H3-H4 chaperones HIR, ASF1, and RTT106 co-operate to maintain promoter fidelity.
J Biol Chem. 2012 Jan 13;287(3):1709-18
Senior Scientist, Princess Margaret Cancer Centre